论文部分内容阅读
目的分析临床未触及乳腺疾病的钼靶乳腺影像报告和数据系统(BI-RADS)分级与细针立体定位手术活检病理结果之间的相关性。方法 88例在临床上未触及乳腺疾病而钼靶检查诊断为BI-RADS分级4级和5级的妇女均接受了细针立体定位手术活检手术,用阳性预测值(PPV)分析BI-RADS分级与细针立体定位手术活检病理结果之间的相关性。结果所有病例的PPV为53.4%。BI-RADS分级4级和5级的PPV分别为50%和100%(P<0.05)。将BI-RADS分级为4级的乳腺病变分为4a、4b和4c后,其PPV则分别是28.3%、72.7%和100%(P<0.01)。在所发现的乳腺恶性肿瘤中,最常见的则是导管原位癌(28.4%)和浸润性导管癌(25.0%)。结论对于临床未触及的乳腺疾病,钼靶BI-RADS分级4级和5级与细针立体定位手术病理诊断结果之间存在显著的正相关性,提示BI-RADS分级能较可靠地诊断临床上未触及的乳腺疾病。
OBJECTIVE: To analyze the correlation between biopsy findings of biopsy and biopsy of the mammographic target Breast Imaging Report and Data System (BI-RADS), a clinical non-invasive breast disease. Methods Eighty-eight women with clinically unaffected breast disease and women diagnosed with grade 4 and grade 5 BI-RADS were treated with fine-needle stereotactic biopsy and positive predictive value (PPV) was used to analyze BI-RADS grade And fine needle stereotactic biopsy pathology results between the correlation. Results The PPV in all cases was 53.4%. BI-RADS grade 4 and 5 PPVs were 50% and 100%, respectively (P <0.05). After dividing the BI-RADS grade 4 breast lesions into 4a, 4b and 4c, their PPVs were 28.3%, 72.7% and 100%, respectively (P <0.01). Of the breast cancers found, the most common ones were ductal carcinoma in situ (28.4%) and invasive ductal carcinoma (25.0%). Conclusions There is a significant positive correlation between the grade 4 and grade 5 of the BI-RADS grading and the pathological diagnosis of small-needle stereotactic surgery in clinically unrelated breast disease, suggesting that BI-RADS classification can be more reliable in the clinical diagnosis Untapped breast disease.